UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum

Gynecologic oncology, 2021-07, Vol.162 (1), p.4-11

2021

Volltextzugriff (PDF)

Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance

Cancers, 2022-02, Vol.14 (4), p.958

2022

Volltextzugriff (PDF)

Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult‐type ovarian granulosa cell tumors

Cancer medicine (Malden, MA), 2024-06, Vol.13 (12), p.e7340-n/a

2024

Volltextzugriff (PDF)

Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer

Frontiers in oncology, 2024-02, Vol.14, p.1291090-1291090

2024

Volltextzugriff (PDF)

Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14 , 958

Cancers, 2022-05, Vol.14 (10), p.2443

2022

Volltextzugriff (PDF)

Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features

Cancer investigation, 2017-08, Vol.35 (7), p.456-462

2017

Volltextzugriff (PDF)

A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor

Gynecologic oncology reports, 2022-12, Vol.44, p.101118, Article 101118

2022

Volltextzugriff (PDF)

Correlation of cardiovascular disease with racial disparities in endometrial cancer outcomes

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5602-5602

2023

Volltextzugriff (PDF)

A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer

Gynecologic oncology reports, 2016-01, Vol.15 (C), p.25-28

2016

Volltextzugriff (PDF)

Exploration and exploitation of hormonal pathways in adult granulosa cell tumors for development of targeted therapeutics (1314)

Gynecologic oncology, 2023-09, Vol.176, p.S192-S192

2023

Volltextzugriff (PDF)

A case series of androgen receptor (AR) inhibition by bicalutamide in combination with leuprolide acetate and exemestane in recurrent AR positive adult-type ovarian granulosa cell tumor (AGCT) (158)

Gynecologic oncology, 2022-08, Vol.166, p.S95

2022

Volltextzugriff (PDF)

Does social vulnerability impact cervical cancer patients undergoing definitive irradiation including brachytherapy? A single institution’s experience (283)

Gynecologic oncology, 2022-08, Vol.166, p.S150

2022

Volltextzugriff (PDF)

Ethical Issues in Aviation

Second edition., 2019

Volltextzugriff (PDF)

Abstract PO-231: Exploring social vulnerability in locally advanced cervical cancer patients undergoing brachytherapy irradiation

Cancer epidemiology, biomarkers & prevention, 2022-01, Vol.31 (1_Supplement), p.PO-231-PO-231

2022

Volltextzugriff (PDF)

Effect of a best-practice alert on the rate of influenza vaccination of pregnant women

Obstetrics and gynecology (New York. 1953), 2012-02, Vol.119 (2 Pt 1), p.301-305

2012

Volltextzugriff (PDF)

Same-day discharge after robotic hysterectomy for gynecologic malignancy: a study of cost analysis and resource utilization

Gynecologic oncology, 2021-08, Vol.162, p.S270-S270

2021

Volltextzugriff (PDF)

Incidence of venous thromboembolism in the gynecologic cancer patient population at a single institution after implementation of pre-operative venous thromboembolism prophylaxis

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e17529-e17529

2018

Volltextzugriff (PDF)

Non-uniform weighting of local motion inputs underlies dendritic computation in the fly visual system

Scientific reports, 2018-04, Vol.8 (1), p.5787-12, Article 5787

2018

Volltextzugriff (PDF)

An open label, nonrandomized, multisite phase II trial combining bevacizumab, atezolizumab, and rucaparib for the treatment of previously treated recurrent and progressive endometrial cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5510-5510

2022

Volltextzugriff (PDF)

PO117

Brachytherapy, 2023-09, Vol.22 (5), p.S125-S126

2023

Volltextzugriff (PDF)

PO117: Can the CDC's Social Vulnerability Index Be Used to Predict Clinical Outcomes in Patients with Cervical Cancer Undergoing Brachytherapy?

Brachytherapy, 2023-09, Vol.22 (5), p.S125-S126

2023

Volltextzugriff (PDF)

Abstract 1702: Sucrose nonfermenting 1-related kinase (SNRK) expression in ovarian cancer and correlation with clinical features

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1702-1702

2016

Volltextzugriff (PDF)

EP075/#462 Radiation quality and workflow in NRG GY017: anti PD-L1 (atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A107-A107

2023

Volltextzugriff (PDF)

PO13

Brachytherapy, 2023-09, Vol.22 (5), p.S71

2023

Volltextzugriff (PDF)

PO13: Bleeding in the Brachytherapy Suite - The Unwanted Surprise

Brachytherapy, 2023-09, Vol.22 (5), p.S71-S71

2023

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(59)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum

Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance

Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult‐type ovarian granulosa cell tumors

Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer

Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14 , 958

Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features

A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor

Correlation of cardiovascular disease with racial disparities in endometrial cancer outcomes

A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer

Exploration and exploitation of hormonal pathways in adult granulosa cell tumors for development of targeted therapeutics (1314)

A case series of androgen receptor (AR) inhibition by bicalutamide in combination with leuprolide acetate and exemestane in recurrent AR positive adult-type ovarian granulosa cell tumor (AGCT) (158)

Does social vulnerability impact cervical cancer patients undergoing definitive irradiation including brachytherapy? A single institution’s experience (283)

Ethical Issues in Aviation

Abstract PO-231: Exploring social vulnerability in locally advanced cervical cancer patients undergoing brachytherapy irradiation

Effect of a best-practice alert on the rate of influenza vaccination of pregnant women

Same-day discharge after robotic hysterectomy for gynecologic malignancy: a study of cost analysis and resource utilization

Incidence of venous thromboembolism in the gynecologic cancer patient population at a single institution after implementation of pre-operative venous thromboembolism prophylaxis

Non-uniform weighting of local motion inputs underlies dendritic computation in the fly visual system

An open label, nonrandomized, multisite phase II trial combining bevacizumab, atezolizumab, and rucaparib for the treatment of previously treated recurrent and progressive endometrial cancer

PO117

PO117: Can the CDC's Social Vulnerability Index Be Used to Predict Clinical Outcomes in Patients with Cervical Cancer Undergoing Brachytherapy?

Abstract 1702: Sucrose nonfermenting 1-related kinase (SNRK) expression in ovarian cancer and correlation with clinical features

EP075/#462 Radiation quality and workflow in NRG GY017: anti PD-L1 (atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer

PO13

PO13: Bleeding in the Brachytherapy Suite - The Unwanted Surprise

Suchergebnisse filtern